Corporate Profile for Orquest, dated May 1, 1998.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-
Published Date: May 1, 1998
Company Name: Orquest, Inc.
Address: 365 Ravendale Drive
Mountain View, CA 94043
Main Telephone
Number: 650/903-4800
Internet Home
Page Address
(URL) x
Chief Executive
Officer: Michael Estes, Ph.D.
Public Relations
Contact: Peter Weissman
Industry: Orthopedic Medical Technology
Company description: Founded in 1994, Orquest is an innovative medical technology company, dedicated to establishing new standards of care Standards of care are medical or psychological treatment guidelines, and can be general or specific. They specify appropriate treatment protocols based on scientific evidence, and collaboration between medical and/or psychological professionals involved in the treatment of a given in orthopedics through biotherapeutic solutions. Orquest has demonstrated unparalleled expertise in integrating materials with biologically active agents for bone and cartilage regeneration CARTILAGE REGENERATION The concept of using cells of the body to regenerate tissue is not new. In the 1980's, Brittberg and Peterson of Gothenburg, Sweden, pioneered the use of tissue cultured cartilage cells, greatly expanded to about 12 million cells, for the purpose of . Orquest's technologies have broad application in areas of major clinical need including spine disorders, bone fractures, osteoporosis and osteoarthritis osteoarthritis or osteoarthrosis or degenerative joint disease Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first. . The Company has focused its initial product development efforts on the two fastest growing segments in orthopedics: spine and trauma. Orquest's first product, Healos, is a natural bone grafting Bone Grafting Definition Bone grafting is a surgical procedure by which new bone or a replacement material is placed into spaces between or around broken bone (fractures) or holes in bone (defects) to aid in healing. product developed for spinal fusion spinal fusion n. A surgical procedure in which vertebrae are joined. Also called spondylosyndesis. Spinal fusion procedures. The Company's second product, Ossigel, is an injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. material for accelerating the healing of bone fractures. To date, Orquest has announced collaborations with Spine-Tech and Hoechst Marion Roussel and has raised $27.5 million in funding from Asset Management, Charter Ventures, Institutional Venture Partners, Mayfield Fund, Sprout Group, State of Michigan, and Weiss, Peck & Greer. CONTACT: Orquest |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion